Navigation Links
Neuro Kinetics Invited to Present at NIH Forum for Investors and Strategic Partners
Date:2/14/2012

PITTSBURGH, Feb. 14, 2012 /PRNewswire/ -- Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com), manufacturers and marketers of noninvasive medical diagnostic equipment used worldwide for neurophysiologic/ neurotologic testing, said today that it is presenting at the National Institutes of Health's (NIH) Feedback Sessions in Washington D.C. on February 28, 2012.

The Feedback Sessions are an invitation only program funded by the NIH in cooperation with the Larta Institute (www.larta.org) called the SBIR Commercialization Assistance Program (CAP).  CAP exposes some of the nation's most promising small life science and healthcare companies and their technologies and business strategies to the investment community, strategic partners and licensees. 

NKI, with assistance from NIH and Larta, is presenting to investors, life science professionals and consultants, and corporate development officers at 8:30 Tuesday morning the 28th. 

"NKI is honored to be one of only forty companies selected to participate," said Vince Kytka, Director of Operations and Marketing. "This program is a great opportunity for accelerating our path to market."

NKI, poised for exciting growth, has had promising success with its I-Portal® technology to diagnose concussions, and, with the support of NIH's SBIR program, it is progressing in the development of its revolutionary I- Portal® Retinopathy product, a new, non-invasive ophthalmic diagnostic device. Initial data suggests this tool can provide early detection of diabetic retinopathy. 

"We are looking forward to this great opportunity to share our progress and potential with such a knowledgeable and influential group," added Howison Schroeder, President and CEO.

Admission to the sessions are limited and by invitation only. If you are interested in attending, please send your contact info to Tracey Zimmerman at tzimmerman@neuro-kinetics.com, or call (412) 963-6649. 

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (NKI) is the world leader in non-invasive diagnostics using its I-Portal® eye tracking technology. The eye is the portal to the brain and research has shown the detection of abnormal eye reflexes can indicate the presence of over 200 diseases and medical conditions.

For more than 25 years, NKI has supplied comprehensive neuro-otologic diagnostic tools to audiologists, ENTs, neuro-otologists, neuro-ophthalmologists and neurologists around the globe.  The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services.


'/>"/>
SOURCE Neuro Kinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Iron-moving malfunction may underlie neurodegenerative diseases, aging
2. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
3. Stabilizing force for good communication between neurons and muscle cells found
4. Researchers identify promising gene target for neuroblastoma therapy
5. How neuronal activity leads to Alzheimers protein cleavage
6. Mediator in communication between neurons and muscle cells found
7. 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
8. A double-barreled immune cell approach for neuroblastoma
9. Protecting neurons could halt Alzheimers, Parkinsons diseases
10. Neuroinformatics special issue spotlights the Neuroscience Information Framework
11. Bipolar disorder genes, pathways identified by Indiana University neuroscientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
(Date:10/9/2017)... Jupiter, FL (PRWEB) , ... October 09, 2017 , ... ... episode, scheduled to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on ... Agriculture industry is faced with the challenge of how to continue to feed a ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... consulting for microscopy and surface analysis, Nanoscience Instruments is now expanding into ... a broad range of contract analysis services for advanced applications. Services will ...
(Date:10/6/2017)... ... October 06, 2017 , ... On Tuesday, October 24th, ABC² ... the first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be ... and open to the public, but registration is required. , WHAT: ABC² ...
Breaking Biology Technology: